[ad_1]
Gauchar disease is a genetic disorder when the body is unable to break some fat, causing fat to accumulate in the cells. In an interview with HT lifestyle, Dr. Ankush Golhar, Lever Transplant and HPB Surgeon, Jupiter Hospital, Thane said, “Gauchar disease is caused by mutation in GBA genes, which is responsible for encoding enzyme glucorrhobrosides, which is a lipid. Also read Genetic disorders in India: normal types, risk factor, transmission
Gauchar Disease: Types and Symptoms
Type 1 (non-neuronopathic): It is the most common form and accounts for about 90% of all cases. It mainly affects the spleen, liver and bone marrow, but does not affect the nervous system. Symptoms include spleen (splenomegaly) and liver (hepatomegaly), bone pain or fracture, fatigue and easy injury.
Type 2 (acute neuronopathic): This form is very rare and more severe, with rapid progress that leads to neurological damage. Infants with type 2 gauchar disease may experience symptoms such as poor muscle tone, seizures, and developmental delays, often die at an early age.
Type 3 (chronic neuronopathic): Type 3 is a more moderate form of disease, where neurological symptoms develop later in childhood or adolescence. Affected individuals may experience a wide range of neurological problems, including the issue of eye movement, coordination difficulties and seizures, as well as general symptoms for type 1. Also read Anderson-Phabry disease: Type, signs and symptoms, diagnosis, treatment of rare genetic disorders affects organs
Gauchar Disease: Diagnosis and Treatment
“Diagnosis of gauchar disease typically involves a combination of clinical evaluation, family history and laboratory tests. Glucockerabrocedase is important in identifying a blood test disorder to measure the enzyme activity. The genetic test can confirm the diagnosis by identifying the interaction in GBA genes,” Dr. Enkush Galer told.
While there is no cure in Gauchar disease yet, it can be treated. There are first aid options:
Enzyme Replacement Therapy (Ert): This includes regular intravenous infections of a synthetic version of missing enzymes. ERT is shown to reduce spleen and liver size, improve bone health and reduce other symptoms, although it does not address neurological issues linked to type 2 and type 3.
Substrate Reduction Therapy: This oral drug helps reduce the production of glucococcibroside, preventing its accumulation in cells. It is usually used for patients who cannot pass through ERT or for people with milk forms. Also read What is hemocromatosis, a rare genetic disorder that causes limb’s dysfunction?
Note the readers: This article is only for informative purposes and is not an option for professional medical advice. Always consult your doctor with any question about a medical condition.
[ad_2]
